Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Private Placement Adding $27M To VaxGen’s Anthrax Drug Work

Feb. 13, 2006

By Jennifer Boggs

After First Product Approval, BioMimetic Seeks $50M IPO

Feb. 13, 2006

By Jennifer Boggs

Inflabloc Adds Cancer Drugs Through Merger, Raises $6M

Feb. 10, 2006

By Jennifer Boggs

Inflabloc Adds Cancer Drugs Through Merger, Raises $6M

Feb. 10, 2006

By Jennifer Boggs

Immtech Prices $16M Public Offering; EpiCept Adds $11M

Feb. 9, 2006

By Jennifer Boggs

Immtech Prices $16M Public Offering; EpiCept Adds $11M

Feb. 9, 2006

By Jennifer Boggs

ARYx Series E Gets $30M To Fund Proof Of Concept

Feb. 8, 2006

By Jennifer Boggs

ARYx Series E Gets $30M To Fund Proof Of Concept

Feb. 8, 2006

By Jennifer Boggs

QuatRx Files $86M IPO To Push Clinical Development

Feb. 7, 2006

By Jennifer Boggs

A month after starting its first Phase III trial, QuatRx Pharmaceuticals Co. filed for its initial public offering, hoping to raise $86.25 million. (BioWorld Today)

QuatRx Files $86M IPO To Push Clinical Development

Feb. 7, 2006

By Jennifer Boggs

A month after starting its first Phase III trial, QuatRx Pharmaceuticals Co. filed for its initial public offering, hoping to raise $86.25 million. (BioWorld Today)

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 3, 2025.
Medtronic, Recor commence hostilities over RDN patents
BioWorld MedTech
The renal denervation patent wars are now in full swing, with Medtronic plc and Recor Medical LLC landing the first blow in this chapter of the med tech patent...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
ADPD 2025: Emerging strategies fueling Alzheimer’s disease research
BioWorld Science
During the first oral sessions on Translational Drug Discovery at the 19th Alzheimer’s & Parkinson’s Diseases (ADPD) Conference, Beka Solomon from Tel Aviv...